Us Bancorp \De\ Poseida Therapeutics, Inc. Transaction History

Us Bancorp \De\

$75.6 Billion
Q4 2024

A detailed history of Us Bancorp \De\ transactions in Poseida Therapeutics, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 26 shares of PSTX stock, worth $247. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$247

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2024 Feb 05, 2025	BUY	$2.37 - $9.6 $61 - $249	26 New	26 $0
Q1 2024 May 07, 2024	BUY	$2.76 - $4.13 $14,351 - $21,476	5,200 New	5,200 $16,000

Others Institutions Holding PSTX

# of Institutions

111

Shares Held

39.7M

Call Options Held

451K

Put Options Held

146K

Pentwater Capital Management LP Naples, FL

5.98M
Shares

$56.8 Million
0.18% of portfolio
Black Rock Inc. New York, NY

4.91M
Shares

$46.6 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.83M
Shares

$36.4 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

2.19M
Shares

$20.8 Million
0.0% of portfolio
Alpine Associates Management Inc. Englewood Cliffs, NJ

2.02M
Shares

$19.2 Million
1.2% of portfolio

View Full List

About Poseida Therapeutics, Inc.

Ticker PSTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,775,600
Market Cap $815M
Description
Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...

More about PSTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account